The field of metabolic research and cellular signaling therapies is undergoing an unprecedented expansion in 2026. For years, laboratories and chemical researchers relied on single-target compounds that offered limited insight into complex endocrine pathways. This diagnostic limitation has shifted global scientific focus toward multi-receptor metabolic tools that manipulate dual pathways simultaneously. For institutions looking to […]